for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

Background The subcutaneous implantable cardioverter–defibrillator (ICD) was designed to
avoid complications related to the transvenous ICD lead by using an entirely extrathoracic …

Background Subcutaneous implantable cardioverter‐defibrillators (S‐ICDs) have been of
great interest as an alternative to transvenous implantable cardioverter‐defibrillators (TV …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is developed to
overcome lead-related complications and systemic infections, inherent to transvenous ICD …

Importance In patients with sarcoidosis with suspected cardiac involvement, late gadolinium
enhancement (LGE) on cardiovascular magnetic resonance imaging (CMR) identifies those …

Background The subcutaneous implantable cardioverter–defibrillator (ICD) is associated
with fewer lead-related complications than a transvenous ICD; however, the subcutaneous …

Background A small proportion of patients undergoing primary prophylactic implantation of
implantable cardioverter defibrillators (ICDs) experiences malignant arrhythmias. We …

Cardiac implantable electronic devices (CIED) are potentially life-saving treatments for
several cardiac conditions, but are not without risk. Despite dissemination of recommended …

Background: Implantable cardioverter defibrillators (ICDs) improve survival in patients at risk
for cardiac arrest, but are associated with intravascular lead-related complications. The …

Background Early subcutaneous implantable cardioverter-defibrillator (S-ICD) studies
included atypical cohorts of patients who were younger with fewer comorbidities. Recent S …